Preclinical investigation of [149Tb]Tb-DOTATATE and [149Tb]Tb-DOTA-LM3 for tumor-targeted alpha therapy
Ana Katrina Mapanao, Sarah D. Busslinger, Avni Mehta, Kristel Kegler, Chiara Favaretto, Pascal V. Grundler, Zeynep Talip, U. Köster, K. Johnston, Roger Schibli, Nicholas P. van der Meulen, Cristina Müller
Topics & Concepts
DOTASomatostatin receptorMedicineRadionuclide therapyViability assayIn vivoImaging agentCancer researchPharmacologyNuclear medicineChemistrySomatostatinIn vitroInternal medicineChelationBiochemistryBiologyBiotechnologyOrganic chemistryRadiopharmaceutical Chemistry and ApplicationsNeuroendocrine Tumor Research AdvancesPeptidase Inhibition and Analysis